Shafaq Zia is a science journalist and a graduate student in the Graduate Program in Science Writing at the Massachusetts Institute of Technology. Previously, she was a reporting intern at STAT, covering the COVID-19 pandemic and the latest research in health technology.
Shafaq Zia
From this contributor
Spotted around the web: COVID-19 during pregnancy, sleep problems, eugenics
Here is a roundup of news and research for the week of 6 June.
Spotted around the web: COVID-19 during pregnancy, sleep problems, eugenics
New resource tracks genetic variations in Han Chinese populations
An online database called NyuWa catalogs genetic variations among nearly 3,000 individuals and provides a comprehensive reference genome for the Han people.
New resource tracks genetic variations in Han Chinese populations
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.